Resultaten

…a randomized, open-label, phase 3 study Usmani SZ, Quach H, Mateos MV. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated…

the last decade: a report from the European Group for Blood and Marrow Transplantation. Hematologica 2007;92:11-18. Marsh JCW et al. Guidelines for the diagnosis and management of aplastic anaemia. Br…

…Brockow K, et al.; Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European…

…can be an effective treatment of choice and positron emission tomography with 18FDG can be used for determining the extent of disease and for follow-up in RDD. Bateman AC, Deheragoda…

…diagnosis, and treatment. Eur J Haematol. 2016;96:447-60. Commander, L.A., Seif, S.A., Insogna, I.G., Rheingold, S.R. Salvage therapy with nelarabine, etop0side, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma….

…with a combination of rituximab and temozolomide. Neurology 2004;63(5):901-903. Soussain C, Hoang-Xuan K, Taillandier L et al. Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS…

…onder andere af van de symptomatologie, comorbiditeit, gebruik van antistolling, ingrepen in de nabije toekomst en leeftijd. In de praktijk wordt vaak een grens van 30×109/L of lager aangehouden, al…

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 27-9-2024, 4:03